Upcoming SlideShare
Loading in...5

Like this? Share it with your network








Total Views
Views on SlideShare
Embed Views



0 Embeds 0

No embeds



Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
Post Comment
Edit your comment

Exams Presentation Transcript

  • 1. Exams & Grading: 85% of the final grade : Exam scores from each of the three Sections will represent one-third of a total of 85% of the final grade for the course. Two exams will be administered in Section I, while one exam each will be given in Sections II & III. Sectional exams will be based on Tuesday-Friday lectures and employ a mix of short answer & essay questions. 10% of the final grade : The Final Exam on the “Integrative Perspective on Diabetes” will comprise 10% of the final grade. 5% of the final grade : The average score for the written responses to pre-assigned topics for Monday Discussions will comprise a total of 5% of the final grade. A traditional numerical scoring system will be used to generate a final letter grade - A= 90-100% B=80-89% C=70--79%, D=60-69%, and F= 59% or less. FIS 2006
  • 2. diabetes
    • Type I
      • Autoimmune destruction of β -cells of pancreas
    • Type II
      • Insulin resistance coupled with deficient release
    • hyperglycemia & hyperlipidemia leading to atherosclerosis, neuropathy & infection
  • 3. FIS 2006 (Diabetes) Version date: Aug 03, 2006 Final Exam: Integrative Perspective on Diabetes - 1 0% Final Grade Types of Questions: Contrast the etiologies of Type I & Type II diabetes, and discuss the mechanisms for the metabolic derangements leading to hyperglycemia and hyperlipidemia. Focus on a specific organ system (vascular, neural, host-defense) subjected to long-standing hyperglycemia, hyperlipidemia and other abnormalities secondary to poorly controlled Type I or II diabetes: - Discuss the mechanisms for pathology; - Discuss the mechanisms for pharmacological prophylaxis and/or treatment of organ system dysfunction.
  • 4. FIS Organization: Exam #1- Basic Principles -> diabetes Exam #2- Neurobiology -> diabetes Exam #3- Endocrinology -> diabetes Exam #4- Immunology & Bacterial Pathogenesis -> diabetes ↓ ↓ (Exam #5: final)
  • 5. FIS 2006 (Diabetes) Lectures: Sept 2 - Diabetes & Polyphagia Oct 06 - Insulin Oct 10 - Counter Regulatory Hormones Oct 18, 18 & 20 - Homeostasis & Responses to External Environment Nov 17 – Immunology of Diabetes Monday Discussions : (student-driven lecture questions, student-driven journal clubs & faculty-driven discussion of relevance of lectures to diabetes). Resource Text: Ellenberg & Rifkin’s DIABETES MELLITUS, sixth edition, Porte et al ., Neurobiology Sept 11 - Diabetes & Neuropathy Journal Club Organization Sept 18 - Diabetes & Neuropathy Journal Club Sept 25 - Diabetes & Neuropathy Journal Club Oct 02 - Diabetes, Erectile Dysfunction & Viagra Basic Principles & Endocrinology Aug 28- Diabetes & Atherosclerosis Oct 09 - Diabetes, Insulin Resistance & Metabolic Syndrome Oct 16 – Pharmacological Management of Diabetes Oct 23 - Diabetes, Insulin Resistance & Polycystic Ovary Syndrome Immunology & Bacterial Pathogenesis: Nov 27 - Immunology of Diabetes Dec 04- Infections & Diabetes
  • 6. FIS & Diabetes: Type I Diabetes: Autoimmune destruction of β -cells of pancreas Type II Diabetes: Insulin Resistance Pathology of Diabetes: Atherosclerosis Neuropathy Susceptibility to Infection Pharmacological Prevention: Type I- Insulin Replacement Regimens Type II- Insulin Secretogogues - Insulin Sensitizers Pharmacological Treatment: examples: Viagra & Erectile Dysfunction Aldose Reductase Inhibitors & Neuropathy Insulin Sensitizers & Polycystic Ovary Syndrome
  • 7. Atherosclerosis: Abnormal vascular smooth muscle migration to sub-endothelial space and proliferation
    • Key abnormalities:
    • smooth muscle
    • lipid
    • Significance:
    • ↓ perfusion
    • infarction
  • 8.  
  • 9. Atherosclerosis
    • Insult to Endothelium
    • potential mechanisms include non-enzymatic glycosylation
    • & lipid-induced macrophage growth factors
    • Consequence & Focus for FIS Discussion:
          • defective inhibitory proteoglycans of endothelial extracellular matrix in contact with smooth muscle cells
          • deficient release of inhibitory NO to smooth muscle cells
          • abnormal smooth muscle migration & proliferation
  • 10. Diabetic Neuropathy
  • 11. mechanism for diabetes-induced neurodegeneration
    • Sorbitol
        • glucose -> sorbitol -> fructose
          • osmotic perturbations due to sorbitol (hydroxyated glucose),
            • “ trapped” intracellularly
            • specific to neurons (aldose reductase)
            • elevated intraneuronally in diabetes due to hyperglycemia & insulin-independent neuronal glucose uptake
          • oxidative stress due to depletion in NADPH by aldose reductase
  • 12. Diabetes & Neuropathy: 4 Journal Clubs
    • Descriptive changes:
    • Diabetes-induced changes in morphology & electrophysiology
    • Causal role of sorbitol:
    • Diabetes-induced intra-neuronal sorbitol, potentially leading to perturbations via osmotic distortion &/or oxidative stress
    • 3) Abnormal protein phosphorylation of neuronal structure:
    • Diabetes-induced abnormal neurophilament phosphorylation, potentially leading to impaired structural/functional integrity and ultimately ↓ conduction & terminal degeneration.
    • 4) Loss of neurotransmitter synthesis in nerve terminal:
    • Diabetes-induced degeneration of nitrergic neurons, specifically loss of NO synthesis, potentially leading to impaired vasodilation & erectile dysfuction
  • 13. Diabetes & Immunology/Bacterial Pathogenesis
    • Etiology of Type I diabetes:
      • Autoimmune destruction of β -cell
    • Infections & diabetes
      • sensation (neural)
      • perfusion (vascular)
      • substrate for bacterial growth
      • host defense
  • 14. Version date: 2006 FIS Final Exam: Sample Questions Q: Contrast the etiologies of Type I & Type II diabetes. (Basis for Answer: Type I- Autoimmune & Type II- Insulin Resistance) Q: Discuss the mechanisms for the potential pathological changes in a specific organ system, secondary to long-standing hyperglycemia and/or hyperlipidemia of Type II diabetes. (Basis for Answer: Erectile Dysfunction due to both vascular occlusion (atherosclerosis) & deficient NO release from neurons responsible for vasodilation Q: Review the pharmacological basis, including mechanism of action, for a prophylaxis and amelioration of this specific organ system disease - or its consequences. (Basis for Answer: Prophylaxis- insulin sensitizing drugs; Treatment- Viagra, a cyclic GMP phosphodiesterase inhibitor)